Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Frontal brain lobe impairment in obstructive sleep apnoea: a proton MR spectroscopy study

M. Alchanatis, N. Deligiorgis, N. Zias, A. Amfilochiou, E. Gotsis, A. Karakatsani, A. Papadimitriou
European Respiratory Journal 2004 24: 980-986; DOI: 10.1183/09031936.04.00127603
M. Alchanatis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N. Deligiorgis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N. Zias
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Amfilochiou
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. Gotsis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Karakatsani
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Papadimitriou
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Patients with obstructive sleep apnoea syndrome frequently have cognitive deficits, especially related to executive functions, which cannot be fully explained by daytime sleepiness and are partial irreversible after nasal continuous positive airway pressure treatment. The causal mechanism of these cognitive deficits is not yet known, but it has been proposed that they are associated with chemical and structural brain cell injury. The aim of this study was to investigate brain metabolism in patients with sleep apnoea syndrome.

Twenty-two patients with severe sleep apnoea and 10 healthy volunteers of comparable age were studied using single voxel proton magnetic resonance spectroscopy. Magnetic resonance spectra were obtained from prefrontal cortex, parieto-occipital and frontal periventricular white matter.

N-acetylaspartate-to-creatine and choline-to-creatine ratios were significantly lower in the frontal white matter of obstructive sleep apnoea patients when compared to controls. Absolute concentrations of N-acetylaspartate and choline were also significantly reduced in the frontal white matter of patients with sleep apnoea.

Frontal lobe white matter lesions are known to be associated with cognitive executive dysfunction. The findings of this study may offer an explanation for the sometimes irreversible cognitive deficits associated with sleep apnoea.

  • Cerebral metabolism
  • proton magnetic resonance spectroscopy
  • sleep apnoea syndrome

Obstructive sleep apnoea (OSA) syndrome (OSAS) is a common disorder occurring in up to 4% of the general adult population 1. Cognitive impairment has been repeatedly reported in OSA patients. The areas most frequently affected are general intellectual functioning, attention, memory and, inparticular, executive functions, such as problem solving, planning of goal-oriented behaviour and mental flexibility 1,2. To date, the pathophysiology of the cognitive deficits reported in OSA patients has not been determined. Some researchers argue that excessive daytime somnolence is the leading cause of the cognitive deficits, while others propose that nocturnal hypoxaemia is the main contributing factor 1,2. Moreover, several studies have shown that executive dysfunction in OSA patients may persist even after nasal continuous positive airway pressure (nCPAP) treatment 2–4. Cognitive executive functions are associated with specific prefrontal-subcortical brain circuits 5, thus it has been proposed that OSAS may promote irreversible anoxic brain damage affecting the prefrontal cortex 4, 6.

Proton magnetic resonance spectroscopy (1H MRS) provides a noninvasive in vivo assessment of brain metabolism. 1H MRS has been applied to the study of many brain disorders, including Alzheimer's disease, brain tumours, epilepsy, multiple sclerosis, leukodystrophies and mitochondrial disorders 7, 8.

The aim of this study was to detect possible metabolic abnormalities in the brain of patients with severe OSAS using single voxel 1H MRS. Both the prefrontal cortex and the frontal periventricular white matter were examined, as these regions are associated with executive cognitive dysfunction 5, which is frequently reported in OSA patients. The parieto-occipital periventricular white matter was also examined, asspectroscopic abnormalities have been previously reported in OSA patients 9, 10.

Materials and methods

Study subjects

Twenty-two consecutive patients with severe OSAS who fulfilled the following inclusion criteria were enrolled in this study: apnoea/hypopnoea index (AHI) >30, age <65 yrs, no history of stroke, and absence of neurological disease or history of head injury. Patients with claustrophobia or metallic implants were excluded. All patients were diagnosed in the Sleep Laboratory of the Pulmonary Dept of the Medical School (Athens University), in “Sotiria” Hospital for Chest Diseases, or in the Sleep Laboratory of “Sismanoglio” Hospital (both Athens, Greece), between June and December 2002. Ten healthy male volunteers of comparable age were used as the control group. The Ethics Committees of both hospitals approved the study, and all patients and control subjects gave written informed consent.

Study design

All subjects underwent a full-night polysomnography (Embla, Flaga ht; Medical Devices, Reykjavik, Iceland), with recordings of the following: electroencephalogram; electrooculogram; chin electromyogram; electrocardiogram; oral and nasal flow; abdominal and thoracic movements; oxyhaemoglobin saturation; and snoring 11. Excessive daytime sleepiness was assessed by using the Epworth Sleepiness Scale (ESS). Within 2 weeks of polysomnography and before the initiation of nCPAP treatment, all eligible patients, as well as control subjects, underwent single voxel brain 1H-MRS.

Methods

Spectroscopy was performed at 1.5 Tesla using PROBE (Signa Hispeed; General Electric, Milwaukee, WI, USA). Prior to 1H MRS, axial T1-weighted and FLAIR (fluid-attenuated inversion recovery) images were obtained, in order to exclude neurological disease and to localise the voxels. Two OSA patients had punctuated white matter hyperintensities. Voxels were carefully placed outside these lesions, in normal-appearing brain tissue. No magnetic resonance imaging abnormalities were found in the control group. Proton spectra were obtained from: 1) right parieto-occipital whitematter, next to the occipital horn of the lateral ventricle; 2) left frontal white matter, next to the frontal horn of the lateral ventricle; and c) left prefrontal cortex (figs 1a⇓, 2a⇓ and 3a⇓).

Fig. 1.—
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1.—

a) Location of the examined voxel in the right parieto-occipital white matter (PWM), next to the occipital horn of the lateral ventricle (see box). b) A representative spectra of an obstructive sleep apnoea patient from PWM. c) A representative spectra of a control subject from PWM. #: myo-inositol; ¶: choline; +: creatine; ƒ: N-acetylaspartate.

Fig. 2.—
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 2.—

a) Location of the examined voxel in the left frontal white matter (FWM), next to the frontal horn of the lateral ventricle (see box). b) A representative spectra of an obstructive sleep apnoea patient from FWM. c) A representative spectra of a control subject from FWM. #: myo-inositol; ¶: choline; +: creatine; ƒ: N-acetylaspartate.

Fig. 3.—
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 3.—

a) Location of the examined voxel in the left prefrontal cortex (PFC) (see box). b) A representative spectra of an obstructive sleep apnoea patient from PFC. c) A representative spectra of a control subject from PFC. #: myo-inositol; ¶: choline; +: creatine; ƒ: N-acetylaspartate.

A single voxel spin-echo PRESS (point-resolved spectroscopy) sequence was used with echo time (tE) 35 ms, repetition time (tR) 1,500 ms and 96 signal acquisitions, resulting in an acquisition time of 3 min per pixel. The choice of single-voxel MRS instead of chemical-shift imaging (CSI) was made for two reasons: first, in order to assure accurate placement of the volume of interest and to avoid signal contamination with unwanted tissue; and, secondly, in order to assure higher accuracy in quantitation, knowing that significant quantitation differences exist across all voxels of a CSI slab. The choice of tR/tE was made basically for signal-to-noise ratio optimisation for the given spectral acquisition time. Voxel volumes were 6.7±1.8 cm3 (mean±sd) for the frontal white matter, 8.2±2.4 cm3 for the posterior white matter and 5±0.8 cm3 for the frontal grey matter. This variability in volumes was necessary in order to ensure that, in spite of individual anatomical differences, only white or only gray matter were included in each voxel. Voxels were placed in the same regions for all subjects, by the same experienced investigator (E. Gotsis), to decrease intra-subject variation. Peaks corresponding to N-acetylaspartate (NAA), creatine (Cr), choline (Cho) and myo-inositol (mI) were measured, and the NAA/Cho, NAA/Cr, Cho/Cr and mI/Cr ratios were calculated 12. The absolute concentrations of NAA, Cho, Cr and mI were also calculated, with direct comparison of patient spectra to the spectrum of an external phantom of known metabolite concentrations (GE phantom of known concentrations), correcting for filling factor differences of the coil for each patient, as well as for the phantom (actually using the head coil transmitter gain in each case). Concentrations were calculated in mmol per kg wet tissue. The use of metabolite ratios in MRS studies reduces systematic errors, because they would affect all metabolites for a particular voxel in the same proportion. However, this method cannot distinguish between numerator and denominator changes. Conversely, the calculation of absolute metabolite concentrations, although sensitive to technical errors, can be very helpful for the interpretation of ratio changes.

Analysis

All values are expressed as mean±sd. The Mann-Whitney U-test was used to compare age, metabolite ratios and concentrations between the two groups. This nonparametric test was chosen because of the small sample size and the lack of previous data showing a normal distribution for the examined ratios and concentrations in OSA patients. Correlations between metabolite ratios, metabolite concentrations and specific respiratory parameters, ESS and age, were determined using Spearman's correlation. A p-value <0.05 was considered statistically significant. A general linear model test (multivariate ANOVA) was used in order to examine the effect of interactions of age, ESS, AHI, minimal nocturnal oxyhaemoglobin saturation (Sa,O2,min), mean nocturnal oxyhaemoglobin saturation (Sa,O2,mean) and absolute time of oxyhaemoglobin saturation <90% during sleep (t<90%) on metabolite ratios and concentrations.

Results

The clinical characteristics of OSA patients and control subjects, as well as statistical comparisons between them, are presented in table 1⇓. Fourteen out of the 22 patients did not have cardiac disease or cardiovascular risk factors, including hypertension, hyperlipidaemia and diabetes mellitus, according to their medical history. Out of the eight remaining patients, one had ischaemic heart disease, one had atrial fibrillation, six had hypertension, two had hyperlipidaemia and two had diabetes mellitus, all under medical treatment.

View this table:
  • View inline
  • View popup
Table 1—

Clinical characteristics of obstructive sleep apnoea (OSA) patients and controls

In comparison to the control group, OSA patients showed a significant reduction in the NAA/Cr and Cho/Cr ratios in frontal white matter (p=0.012 and p=0.008, respectively). Table 2⇓ summarises the results of the comparison of the metabolite ratios between OSA patients and controls in the three examined areas. Figures 1b⇑, 2b⇑, 3b⇑ and 1c⇑, 2c⇑, 3c⇑ display representative spectra of one OSA patient and one control subject, respectively. In figure 4⇓, scatter plot diagrams of NAA/Cr and Cho/Cr ratios in frontal white matter are shown. OSA patients had significantly decreased NAA and Cho absolute concentrations in frontal white matter compared to controls (p=0.04 and p=0.017, respectively), as demonstrated in table 3⇓. No statistically significant differences were found between patients and controls in the parieto-occipital white matter and in the prefrontal cortex, regarding either metabolite ratios or absolute concentrations.

Fig. 4.—
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 4.—

Scatterplots of a) choline (Cho)/creatine (Cr) and b) N-acetylaspartate (NAA)/Cr ratios of controls (○) and obstructive sleep apnoea (•) patients in frontal white matter. ––: mean values. *: p<0.05; **: p<0.01.

View this table:
  • View inline
  • View popup
Table 2—

Comparison of metabolite ratios between obstructive sleep apnoea (OSA) patients and controls

View this table:
  • View inline
  • View popup
Table 3—

Comparison of absolute metabolite concentrations between obstructive sleep apnoea (OSA) patients and controls

In table 4⇓, metabolite ratios of a subgroup (OSA subgroup) of the 22 OSA patients, consisting of those without a history of cardiac disease or cardiovascular risk factors (hypertension, hyperlipidaemia and diabetes mellitus) are compared to controls. This subgroup of 14 OSA patients, without having significant age difference from controls, had statistically significant decreases in NAA/Cr and Cho/Cr ratios in frontal white matter when compared to the control group (p=0.03 and 0.01, respectively). As demonstrated in table 5⇓, Cho concentration was significantly decreased in frontal white matter of the OSA subgroup as compared to controls (p=0.03), whereas NAA showed only a trend to decrement (p=0.09). Correlations between metabolite ratios in all three examined areas, and AHI, Sa,O2,min, Sa,O2,mean and t<90% were not significant.

View this table:
  • View inline
  • View popup
Table 4—

Comparison of metabolite ratios between obstructive sleep apnoea (OSA) subgroup (patients without cardiac disease or cardiovascular risk factors) and controls

View this table:
  • View inline
  • View popup
Table 5—

Comparison of metabolite concentrations between obstructive sleep apnoea (OSA) subgroup (patients without cardiac disease or cardiovascular risk factors) and controls

In the control group, age showed an inverse correlation only with anterior white matter NAA level (r=−0.648, p=0.043). In the same area, the mI/Cr ratio of the control group was correlated with age (r=0.732, p=0.016). Metabolite concentration, as well as metabolite ratios, of the patient group did not correlate with age. The effect of interactions ofage, ESS, AHI, Sa,O2,min, Sa,O2,mean and t<90% on metabolic ratios and concentrations was not statistically significant for the control nor for the patient group. ESS was correlated significantly only with NAA/Cho ratio in the posterior white matter (r=−0.476, p=0.025).

Discussion

In the present study, brain metabolism was investigated in patients with severe OSAS. The results demonstrate a significant decrease in NAA/Cr and Cho/Cr ratios, as wellas a reduction in absolute concentrations of NAA and Cho, in the FWM of OSA patients when compared to controls.

NAA is an intraneuronal molecule and, in the mature brain, it is found only in neurons and axons. NAA is reduced in many brain disorders, in the presence of neuronal and/or axonal loss or dysfunction, such as infarcts, dementia, brain tumours, hypoxic encephalopathy and multiple sclerosis 7,8.

The Cr signal is generated by the sum of creatine and phosphocreatine, and reflects energy metabolites. Because this peak remains relatively stable, it is frequently used as a reference peak to normalise metabolite signal intensities.

mI originates almost exclusively from glial cells. Elevated mI represents both the accumulation of myelin breakdown products and astrocytosis 7, 8, 13.

The Cho peak measures total levels of mobile choline, which include free choline, glycerophosphocholine (a byproduct of phosphatidylcholine breakdown), phosphocholine (a phosphatidylcholine precursor) and minute amounts of acetylcholine. Elevated Cho represents increased membrane turnover or increased cellular density, and it has been reported in cases of active demyelination, brain tumours and glial proliferation 7, 8, 13.

Decreased NAA in the frontal white matter of OSA patients indicates axonal loss and/or dysfunction 7, 8. The deep white matter, where metabolic impairment was found in the current study, seems to be selectively affected in OSAS. Previous studies applying MRS with chemical shift imaging have demonstrated a decrease in the NAA/Cho ratio in the posterior periventricular white matter 9, 10 and lactate production in the centrum semiovale of OSA patients during sleep, indicating that hypoxia is causing anaerobic glycolysis 14. Absolute concentrations were not calculated in these studies, so it is not clear if the decreased ratio was due to a decrease in NAA and/or an elevation in Cho. A recent study, using computed tomography, demonstrated that white matter disease severity in patients with acute stroke and OSAS correlated independently with AHI 15. One possible explanation is that the arterial supply of the deep white matter is not sufficient to compensate for the decreased and fluctuating cerebral perfusion and the impaired cerebral vascular autoregulation that have been reported in OSA patients 10, 16, 17. In fact, the arterial networks of the deep white matter, the so-called internal border zone, are terminals without collaterals or anastomoses 18.

An interesting finding in this study is the decrement of Cho in the frontal white matter of OSA patients. Decreased Cho has been reported in mitochondrial, hypomyelinotic and metabolic diseases, hepatic encephalopathy 7, 8, Grave's disease 19, Lewy body dementia 20, and chronic obstructive pulmonary disease 21. It has been suggested that decreased in vivo Cho levels indicate loss of myelin lipids or phospholipid metabolism dysfunction 17, 18, 22. These results are in agreement with the report of Shim et al. 21. These investigators found a reduction in NAA, Cr and Cho concentrations in the parietal white matter of COPD patients with resting normoxaemia and nocturnal desaturation, a respiratory profile similar to OSAS. A previous study has demonstrated a decrease in Cho metabolites as a consequence of brief ischaemic episodes in an experimental animal model 22. Nevertheless, if chronic haemodynamic impairment were the sole pathogenic factor related to OSA, one would expect elevation of Cho and perhaps of mI due to gliosis and myelin breakdown 13, 18, 23. It is suggested here that a possible interpretation for the Cho decrement is that OSA does not promote gliosis but induces brain metabolic impairment through a unique combination of fluctuating haemodynamic impairment, sleep fragmentation and intermittent hypoxia. Experimental intermittent hypoxia per se can induce neuronal apoptosis and biochemical changes in animals' brains, perhaps in a different manner than chronic sustained hypoxia 24, 25. In addition, recent studies have shown that the prefrontal areas are especially sensitive to sleep deprivation and recovery sleep, presumably because these regions have a unique requirement for sleep-related recovery 6, 26 and that sleep deprivation can alter Cho metabolism. Dorsey et al. 27 found an increase of glycerophosphocholine concentration in healthy volunteers after the recovery night, following a night of sleep deprivation 27. In the current study, although the patients did not have severe sleepiness, ESS score is correlated with NAA/Cho ratio, but only in the posterior white matter.

OSA patients frequently have a combination of vascular risk factors, including hypertension, diabetes mellitus, hyperlipidaemia and central obesity 28. All these factors are associated with increased risk of stroke and could possibly promote brain metabolic impairment. Nevertheless, in the present study, the subgroup of OSA patients without a medical history of cardiac disease or cardiovascular risk factors also had significantly depressed NAA/Cr and Cho/Cr ratios, as well as a diminished Cho concentration in frontal white matter, when compared to controls. This finding suggests that OSAS may promote brain metabolic impairment even in the absence of cardiovascular co-morbidities.

Frontal periventricular white matter lesions, to the best of the current authors' knowledge, have not been reported previously in OSA patients without a history of stroke. Frontal white matter lesions could be associated with the neuropsychological deficits that complicate OSAS. Patients with OSAS frequently have mild impairment in attention-concentration, memory and, in particular, executive functions, such as problem solving, planning of goal-oriented behaviour and mental flexibility, which are sometimes irreversible, even after nCPAP treatment 1–4, 6. Cognitive executive functions are associated with the prefrontal cortex and prefrontal-subcortical brain circuits 5, thus it has been proposed that OSAS induces chemical and structural cellular injury, affecting the prefrontal cortex 4, 6. In the study presented here, no metabolic impairment was found in the examined prefrontal cortex, but it was demonstrated that patients with severe OSAS have metabolic impairment in the frontal white matter. It is, therefore, suggested that these findings may offer an explanation for the specific pattern of cognitive deficits frequently reported in OSA patients, as it is well known that anterior white matter lesions can induce executive dysfunction by interrupting prefrontal-subcortical circuits 5, 29, 30.

An important limitation to this study is the lack of neuropsychological measures in the examined patients, although is well documented that frontal lobe-mediated executive functions are usually impaired in patients with severe OSAS 1. A second limitation is that, because only patients with severe OSA were included, there were not enough variances in the respiratory parameters that could predict the metabolic changes. Kamba et al. 10, who studied OSA patients with wide range of severity (mean AHI 43.78±30), found a significant negative association between AHI and NAA/Cho ratio for the posterior cerebral white matter. A third consideration is about the effect of aging on brain metabolism. MRS studies on the effect of aging on brain metabolites are often discrepant. Results of quantitative MRS studies vary from increased Cr and Chο levels to unchanged or decreased NAA levels and lack of any significant change 22, 31, 32. In the present study, anterior white matter NAA levels of the OSA patient group did not show a significant correlation with aging, but the anterior white matter NAA level of the control group was inversely correlated with aging. These data suggest that, although the age difference between the patient and the control group was not statistically significant, it could be responsible for some of the reported NAA decrement. Nevertheless, if the results were biased by some kind of age effect, one would expect, according to the literature, a decrement in NAA and an increment in Cho, or vice versa, and not a decrement in both metabolites.

In conclusion, the results of this study demonstrate that severe obstructive sleep apnoea syndrome can promote axonal loss or dysfunction, as well as myelin metabolism impairment in the frontal periventricullar white matter. These lesions are in the territory of crucial frontal-subcortical circuits and they could be associated with the, sometimes irreversible, cognitive executive deficits reported in obstructive sleep apnoea patients. Further studies are needed to confirm whether there is a direct correlation between frontal metabolic dysfunction and cognitive impairment in obstructive sleep apnoea patients, and to examine the reversibility of the spectroscopic abnormalities after nasal continuous positive airway pressure treatment.

  • Received November 15, 2003.
  • Accepted August 12, 2004.
  • © ERS Journals Ltd

References

  1. ↵
    Decary A, Rouleau I, Monplaisir J. Cognitive deficits associated with sleep apnoea syndrome: a proposed neuropsychological test battery. Sleep 2000;23:369–381.
    OpenUrlPubMedWeb of Science
  2. ↵
    Engelman HM, Kingshot RN, Martin SE, Douglas NJ. Cognitive function in the sleep apnoea/hypopnoea syndrome (SAHS). Sleep 2000;23:s102–s108.
  3. Naegele B, Pepin JL, Levy P, Bonnet C, Pellat J, Feuerstein C. Cognitive executive dysfunction in patients with obstructive sleep apnoea syndrome (OSAS) after CPAP treatment. Sleep 1998;21:392–397.
    OpenUrlPubMedWeb of Science
  4. ↵
    Bedard MA, Monplaisir J, Malo J, Richer F, Rouleau I. Persistent neuropsychological deficits and vigilance impairment in sleep apnoea syndrome after treatment with continuous positive airway pressure (CPAP). J Clin Exp Neuropsychol 1993;15:330–341.
    OpenUrlPubMedWeb of Science
  5. ↵
    Cummings JL. Frontal-subcortical circuits and human behaviour. Arch Neurol 1993;50:873–880.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    Beebe DW, Gozal D. Obstructive sleep apnoea and the prefrontal cortex: towards a comprehensive model linking nocturnal upper airway obstruction to daytime cognitive and behavioural deficits. J Sleep Res 2002;11:1–16.
    OpenUrlPubMedWeb of Science
  7. ↵
    Castillo M, Kwock L, Mukherji SK. Clinical applications of proton MR spectroscopy. AJNR Am J Neuroradiol 1996;17:1–15.
    OpenUrlPubMedWeb of Science
  8. ↵
    Rudkin TM, Arnold DL. Proton magnetic resonance spectroscopy for the diagnosis and management of cerebral disorders. Arch Neurol 1999;56:919–926.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    Kamba M, Suto Y, Ohta Y, Inoue Y, Matsuda E. Cerebral metabolism in sleep apnoea: evaluation by magnetic resonance spectroscopy. Am J Resp Crit Care Med 1997;156:296–298.
    OpenUrlPubMedWeb of Science
  10. ↵
    Kamba M, Inoue Y, Higami S, Suto Y, Ogawa T, Chen W. Cerebral metabolic impairment in patients with obstructive sleep apnoea syndrome: an independent association of obstructive sleep apnoea with white matter change. J Neurol Neurosurg Psychiatry 2001;71:334–339.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    American Thoracic Society. Indications and standards for cardiopulmonary sleep studies. Am Rev Respir Dis 1989;139:559–568.
    OpenUrlCrossRefPubMedWeb of Science
  12. ↵
    Webb PG, Sailasuta N, Kohler SJ, Raidy T, Moats RA, Hurd RE. Automated single-voxel proton MRS: technical development and multisite verification. Magn Reson Med 1994;31:365–373.
    OpenUrlPubMedWeb of Science
  13. ↵
    Bitsch A, Bruhn H, Vougioukas V, et al. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol 1999;20:1619–1627.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    Kamba M, Inoue Y, Higami S, Suto Y. Age-related changes in cerebral lactate metabolism in sleep-disordered breathing. Neurobiol Aging 2003;24:753–760.
    OpenUrlPubMed
  15. ↵
    Harbison J, Gibson GJ, Birchall D, Zammit-Maempel I, Ford GA. White matter disease and sleep-disordered breathing after acute stroke. Neurology 2003;61:959–963.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    Leung RST, Bradley TD. Sleep apnoea and cardiovascular disease. Am J Respir Cri Care Med 2001;164:2147–2165.
    OpenUrlPubMedWeb of Science
  17. ↵
    Derdeyn CP, Khosla A, Videen TO, et al. Severe hemodynamic impairment and border zone-region infraction. Radiology 2001;220:195–201.
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke 1997;28:652–659.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Elberling TV, Danielsen ER, Rasmussen AK, Feldt-Rasmussen U, Waldemar G, Thomsen C. Reduced myo-inositol and total choline measured with cerebral MRS in acute thyrotoxic Graves' disease. Neutology 2003;60:142–145.
    OpenUrl
  20. ↵
    Molina JA, Garcia-Segura JM, Benito-Leon J, et al. Proton magnetic resonance spectroscopy in dementia with Lewy bodies. Eur Neurol 2002;48:158–163.
    OpenUrlPubMedWeb of Science
  21. ↵
    Shim TS, Lee JH, Kim SY, et al. Cerebral metabolic abnormalities in COPD patients detected by localized proton magnetic resonance spectroscopy. Chest 2001;120:1506–1513.
    OpenUrlCrossRefPubMedWeb of Science
  22. ↵
    Sijens PE, den Heijer T, Origgi D, et al. Brain changes with aging: MR spectroscopy at supraventricular plane shows differences between women and men. Radiology 2003;226:889–896.
    OpenUrlCrossRefPubMedWeb of Science
  23. ↵
    Brooks WM, Mary MH, Kodituwakku PW, Garry PJ, Rosenberg GA. 1H-MRS differentiates white matter hyperintensitiesin subcortical arteriosclerotic encephalopathy from those in normal elderly. Stroke 1997;28:1940–1943.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Reeves SR, Gozal E, Guo SZ, et al. Effect of long-term intermittent and sustained hypoxia on hypoxic ventilatory and metabolic responses in the adult rat. J Appl Physiol 2003;95:1767–1774.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    Douglas RM, Xue J, Chen JY, Haddad CG, Alper SL, Haddad GG. Chronic intermittent hypoxia decreases the expression of Na/H exchangers and HCO3- dependent transporters in mouse CNS. J Appl Physiol 2003;95:292–299.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    Thomas M, Sing H, Belenky G, et al. Neural basis of alertness and cognitive performance impairments during sleepiness. I. Effects of 24 h of sleep deprivation on waking human regional brain activity. J Sleep Res 1999;9:335–352.
  27. ↵
    Dorsey CM, Lukas SE, Moore CM, Parow AM, Villafuerte RA, Renshaw PF. Phosphorous 31 magnetic resonance spectroscopy after total sleep deprivation in healthy adult men. Sleep 2003;26:573–577.
    OpenUrlPubMed
  28. ↵
    Wilkox I, McNamara SG, Collins FI, Grunstein RR, Sullivan CE. “Syndrome Z”: the interaction of sleepapnoea, vascular risk factors and heart disease. Thorax 1998;53:S25–S28.
    OpenUrlAbstract
  29. ↵
    Royall DR. Executive cognitive impairment: a novel prospective on dementia. Neuroepidemiology 2000;19:293–299.
    OpenUrlCrossRefPubMedWeb of Science
  30. ↵
    Kramer JH, Reed BR, Mungas D, Weiner MW, Chui HC. Executive dysfunction in subcortical ischaemic vascular disease. J Neurol Neurosurg Psychiatry 2002;72:217–220.
    OpenUrlAbstract/FREE Full Text
  31. ↵
    Leary S, Brex P, MacManus D, et al. A 1H magnetic resonance spectroscopy study of aging in parietal white matter; implications for trials in multiple sclerosis. Magn Reson Imaging 2000;18:455–459.
    OpenUrlCrossRefPubMedWeb of Science
  32. ↵
    Brooks JCW, Roberts N, Kemp GJ, Gosney MA, Lye M, Whithouse GH. A proton magnetic resonance spectroscopy study of age-related changes in frontal lobe metabolite concentrations. Cerebral Cortex 2001;11:598–605.
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
View this article with LENS
Vol 24 Issue 6 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Frontal brain lobe impairment in obstructive sleep apnoea: a proton MR spectroscopy study
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Frontal brain lobe impairment in obstructive sleep apnoea: a proton MR spectroscopy study
M. Alchanatis, N. Deligiorgis, N. Zias, A. Amfilochiou, E. Gotsis, A. Karakatsani, A. Papadimitriou
European Respiratory Journal Dec 2004, 24 (6) 980-986; DOI: 10.1183/09031936.04.00127603

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Frontal brain lobe impairment in obstructive sleep apnoea: a proton MR spectroscopy study
M. Alchanatis, N. Deligiorgis, N. Zias, A. Amfilochiou, E. Gotsis, A. Karakatsani, A. Papadimitriou
European Respiratory Journal Dec 2004, 24 (6) 980-986; DOI: 10.1183/09031936.04.00127603
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Materials and methods
    • Results
    • Discussion
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • CPAP and measures of cardiovascular risk in males with OSAS
  • The effect of OSAS on sick leave and work disability
  • Heritability of upper airway dimensions derived using acoustic pharyngometry
Show more Original Articles: Sleep-disordered breathing

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society